|
|
|
|
|
|
| One-Step Detection of BRCA2 by Fluorescence Turn-On Sensor |
| REN Lin-jiao1, WEI Ming-hang1, CHEN Qing-hua1*, ZHANG Pei1, YAN Yan-xia2, XUE Meng-xiao1, QIN Zi-rui1, JIANG Li-ying1, 3* |
1. College of Electrical and Information Engineering, Zhengzhou University of Light Industry, Zhengzhou 450002, China
2. College of Computer and Communication Engineering, Zhengzhou University of Light Industry, Zhengzhou 450002, China
3. Academy for Quantum Science and Technology, Zhengzhou University of Light Industry, Zhengzhou 450002, China
|
|
|
|
|
Abstract Screening for BRCA2 gene mutations is clinically important for breast cancer risk assessment, morbidity detection, early diagnosis and gene therapy. Most existing breast cancer gene sensing assays require complex processing, high cost and weak recognition of single-base mutations. To simplify the process of gene-sensor preparation and improve its application possibility, the article realized the detection of BRCA2 in one step through the design of DNA molecular hairpin structure. The molecular hairpin stem contains BRCA2 complementary sequences, and the stem-loop junction is labeled with a tetramethylrhodamine fluorescent group. The target gene can be measured in one step. The optimized experimental results showed that the sensor's detection range was different when the concentration of molecular hairpin was different. The linear detection range of BRCA2 was 1~50 nmol·L-1 at 150 nmol·L-1, 1~100 and 1~200 nmol·L-1 at 300 and 600 nmol·L-1, respectively, and the detection limits for the three concentrations were 0.54, 0.72, and 1.81 nmol·L-1, respectively. In addition, the specificity of the sensor for detecting BRCA2 was outstanding, especially for identifying single-base mutations. The method is simple and specific and can be used not only for early screening of breast cancer in high-risk groups but also for other types of genetic tests, providing a new method with simple preparation and convenient operation for applying genetic sensors.
|
|
Received: 2022-10-31
Accepted: 2023-09-13
|
|
|
|
Corresponding Authors:
CHEN Qing-hua, JIANG Li-ying
E-mail: jiangliying@zzuli.edu.cn; 13937152126@163.com
|
|
[1] Sung H, Ferlay J, Siegel R L, et al. CA: a Cancer Journal for Clinicians, 2021, 71(3): 209.
[2] Wilkinson L, Gathani T. The British Journal of Radiology, 2022, 95(1130): 20211033.
[3] Kwon W K, Jang H J, Lee J E, et al. Cancer Genetics, 2022, 266: 19.
[4] Nielsen F C, Hansen T V, Sørensen C S. Nature Reviews Cancer, 2016, 16(9): 599.
[5] CHEN Hong-yu, ZHANG Jun, QI Ming(陈宏宇, 张 钧, 祁 鸣). Chinese Bulletin of Life Sciences(生命科学) , 2020, 32(4): 366.
[6] Kuchenbaecker K B, Hopper J L, Barnes D R, et al. JAMA, 2017, 317(23): 2402.
[7] Wu N, Wei L, Li L, et al. International Journal of Clinical Oncology, 2022, 27(3): 495.
[8] Ribovski L, Zucolotto V, Janegitz B C. Microchemical Journal, 2017, 133: 37.
[9] Ehzari H, Safari M, Shahlaei M. Microchemical Journal, 2018, 143: 118.
[10] Rasheed P A, Sandhyarani N. Colloids and Surfaces B: Biointerfaces, 2014, 117: 7.
[11] Rasheed P A, Sandhyarani N. Analyst, 2015, 140(8): 2713.
[12] Muti M, Muti M. Electroanalysis, 2017, 29(10): 2208.
[13] Yang H, Gao Y, Wang S, et al. Biosensors and Bioelectronics, 2016, 80: 450.
[14] Liu J, Wang T, Xiao B, et al. Analytical Methods, 2021, 13(5): 712.
[15] Zhong D, Yang K, Wang Y, et al. Talanta, 2017, 175: 217.
[16] Dong B, Nie K, Shi H, et al. Biosensors and Bioelectronics, 2019, 136: 1.
[17] Ai X, Ma Q, Su X. Analytical Biochemistry, 2013, 438(1): 22.
[18] Mao H, Luo G, Zhan Y, et al. Analyst, 2018, 143(14): 3292.
[19] YAN Lei, MAO Xiu-hai, ZUO Xiao-lei(严 磊, 毛秀海, 左小磊). Chinese Journal of Applied Chemistry(应用化学), 2022, 39(5): 837.
[20] Zhang H, Wang L, Jiang W. Talanta, 2011, 85(1): 725. |
|
|
|
